Get started
Author

Xia You

OpenAlex ID: A5023946363
Genetic profile of non‐small cell lung cancer (NSCLC): A hospital‐based survey in Jinhua
2020 · Xianguo Chen, Bo Xu, et al. · Molecular Genetics & Genomic Medicine · 25
PDF
Effects of miR-107 on the Chemo-drug sensitivity of breast cancer cells
2019 · Yong Luo, Tebo Hua, et al. · Open Medicine · 15
PDF
Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas
2023 · Qing Zhang, Yongkun Yang, et al. · Frontiers in Oncology · 9
PDF
Immune Checkpoint Blockade in Chinese Patients With Hepatocellular Carcinoma: Characteristics and Particularity
2022 · Yaoqiang Wu, Han Lin, et al. · Frontiers in Oncology · 7
PDF
A novel TMTC2-NTRK3 fusion in undifferentiated high-grade pleomorphic sarcoma
2022 · Chujie Bai, Lu Zhang, et al. · Journal of Cancer Research and Clinical Oncology · 6
Molecular profiling and prognostic analysis in Chinese cholangiocarcinoma: an observational, retrospective single-center study
2023 · Changkun Zhang, Xia You, et al. · Investigational New Drugs · 5
Case Report: Benefits of a NSCLC Patient With EGFR A289G/F287_G288insHA cis Mutations From Immunotherapy in Combination With Antiangiogenesis and Chemotherapy and Sequential Treatment of EGFR-TKI
2022 · He Zhang, Weiwei Dong, et al. · Frontiers in Oncology · 3
PDF
Comprehensive study of gene fusions in sarcomas
2024 · Nan Chen, Qin Zhang, et al. · Investigational New Drugs · 2
Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Induced Radical Surgery in Oligometastatic Non–Small Cell Lung Cancer: A Case Report
2024 · Huaiyu Wang, Zaiwen Fan, et al. · The Oncologist · 2
PDF
Alterations of the tumor microenvironment (TME) in recurrent glioblastoma following apatinib in combination with temozolomide.
2024 · Junping Zhang, Jingjing Ge, et al. · Journal of Clinical Oncology · 1
PDF
Different genomic profiling of sarcoma between Western and Chinese population.
2021 · Sheng Teng, Yun Yang, et al. · Journal of Clinical Oncology · 1
A possible EGFR TKIs resistance mechanism of lung adenocarcinoma patients with a novel EGFR exon 20-ins mutation: A case report
2020 · Ping Liang, Lijuan Qi, et al. · Lung Cancer · 1
Detection and surveillance of circulating tumor cells in sarcoma for predicting therapy response and prognosis.
2024 · Qing Zhang, Zhe Wang, et al. · Journal of Clinical Oncology
PDF
Prognostic values of immune landscape in Ras-mutant colorectal cancer peritoneal metastases.
2022 · Dong Yan, Lixin Sun, et al. · Journal of Clinical Oncology
A Potential Prognosis and Immune Biomarker in Cancer: DICER1
2022 · Lewen Bao, Xia You, et al. · Research Square
PDF
Relationship between DICER1 mutations and immunotherapy biomarkers in solid tumors.
2021 · Jie Gao, Xia You, et al. · Journal of Clinical Oncology
A pan-cancer study on characteristic of CDK4/6 amplification between Chinese and Western patients.
2021 · Yamin Zhang, Zilin Cui, et al. · Journal of Clinical Oncology
Association of MUC16 mutations with immunotherapy biomarkers in Chinese non-small cell lung cancer patients.
2021 · Tao Han, Taiyan Guo, et al. · Journal of Clinical Oncology
Association of LRP1B mutants with immune biomarkers in Chinese non-small cell lung cancer patients.
2021 · Yi Zhang, Taiyan Guo, et al. · Journal of Clinical Oncology
Genetic alterations in MSS and TMB-H Chinese colorectal cancer patients.
2021 · Shuangyi Ren, Taiyan Guo, et al. · Journal of Clinical Oncology
Works count: 21
Citation count: 77
H-index: 5
I10-index: 2
Year
Topic
Type